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Abstract
Immunological pressure encountered by protozoan parasites drives the selection of strategies to modulate or avoid the
immune responses of their hosts. Here we show that the parasite Entamoeba histolytica has evolved a chemokine that
mimics the sequence, structure, and function of the human cytokine HsEMAPII (Homo sapiens endothelial monocyte
activating polypeptide II). This Entamoeba EMAPII-like polypeptide (EELP) is translated as a domain attached to two different
aminoacyl-tRNA synthetases (aaRS) that are overexpressed when parasites are exposed to inflammatory signals. EELP is
dispensable for the tRNA aminoacylation activity of the enzymes that harbor it, and it is cleaved from them by Entamoeba
proteases to generate a standalone cytokine. Isolated EELP acts as a chemoattractant for human cells, but its cell specificity
is different from that of HsEMAPII. We show that cell specificity differences between HsEMAPII and EELP can be swapped by
site directed mutagenesis of only two residues in the cytokines’ signal sequence. Thus, Entamoeba has evolved a functional
mimic of an aaRS-associated human cytokine with modified cell specificity.
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Introduction
Entamoeba histolytica is an amitochondriate unicellular protozoan
and the leading cause of dysenteric human deaths in the world [1].
The infection cycle of E. histolytica involves the colonization of the
gut and, in more severe cases, the penetration of the gut
ephitelium by the parasite. Crossing of the epithelial barrier in
the gut relies on the ability of the pathogen to induce local
inflammation and apoptosis of epithelial cells [2,3,4]. Once the
parasite has traversed the epithelial gut barrier it can reach
internal organs and cause systemic infections and internal lesions
such as amebic liver abscesses (ALA) [5].
ALA formation starts with the interaction of Entamoeba
trophozoites with liver endothelial cells [6] that triggers cytokine
production and the recruitment of neutrophils and macrophages
around each individual parasite, forming a granuloma [7,8]. This
immune response causes acute inflammation and massive
trophozoite killing [9], while surviving amoebae divide causing
abscesses [10]. In general, host immune responses during
protozoan infections are met by passive and active strategies
evolved by the parasites to modulate and minimize their effect
[4,11,12]. For example, Entamoeba MLIF (Monocyte Locomotion
Inhibitory Factor) is an immunosupressor pentapeptide that is
released by the ameba to disturb cytokine and chemokine
production by host immune cells [13].
Aminoacyl-tRNA synthetases (aaRS) are multi-domain proteins
responsible for the aminoacylation of transfer RNAs. In many
species aaRS, and homologous proteins, are implicated in other
metabolic pathways, cell signaling mechanisms, and developmen-
tal processes [14,15,16]. These non canonical aaRS functions are
often carried out by newly evolved domains, particularly in
mammalian enzymes [17]. For example, WHEP domains in
mammalian Glutamyl-Prolyl-tRNA synthetase control gene ex-
pression after phosphorylation triggered by interferon-c (IFN-c)
[18,19,20]. These new activities may require the proteolytic
processing of the aaRS, or an alternative splicing of their genes
[21,22,23]. Non canonical aaRS activities have also been
identified in protozoans [24].
Eukaryotic cytoplasmic aaRS form a multi-enzyme complex
composed of up to nine individual aaRS [25]. aaRS complexes are
structurally stable and assemble around three additional proteins,
known as aaRS complex-inteacting multifunctional proteins 1–3
(AIMP1, AIMP2, and AIMP3), which also act as cytokines
[26,27,28]. AIMP1 can be proteolytically cleaved from the
complex to generate a protein known as endothelial monocyte
activating polypeptide II (EMAPII) [29]. EMAPII was first
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characterized as a secreted cytokine from mouse tumors and has
since been reported to be active in a large number of cell signaling
and developmental pathways [30]. In humans, EMAPII (HsE-
MAPII) is a wide acting cytokine that induces apoptosis and
migration in endothelial cells, and migration of inflammation
related cell types, like macrophages and monocytes.
Homologous sequences to EMAPII can be found as domains of
mammalian tyrosyl-tRNA synthetases (YRS). EMAPII-like do-
mains in mammalian YRS are proteolytically cleaved and act as
cytokines (HsCtYRS) [23]. EMAPII-like domains are also found in
bacterial methionyl-tRNA synthetases, where they play a role in
tRNAMet aminoacylation [31].
We have discovered that, in the genus Entamoeba, methionyl-
and lysyl-tRNA synthetases (EhMRS and EhKRS) share an almost
identical C-terminal domain (99% sequence identity in their last
166 amino acids). We have labeled these domains as EhCtMRS
(residues 588 to 754 of EhMRS) and EhCtKRS (residues 603 to
769 of EhKRS), respectively. Due to their extreme sequence
identity, we will generally refer to these domains as Entamoeba
EMAPII-like polypeptide (EELP). This domain is also highly
similar to HsEMAPII. To our knowledge, this is the first example
of two aaRS of different classes [32] containing a structurally
identical domain, and the first report of an EMAPII-like domain
attached to a KRS.
The cytokine activities of aaRS-related domains have been
partially characterized in mammals, but no cell signaling activity
has been reported for this kind of molecule in unicellular
eukaryotes. Moreover, the actual biological role of EMAPII
remains controversial. Here we characterize the role of the
EMAPII-like domains found in Entamoeba. Our results show that
the two copies of EELP are closely co-evolving in a process
unrelated to the tRNA aminoacylation reaction. These domains
are localized to the surface of the parasite, and the full length
aaRSs that initially contain them are proteolytically processed to
produce the isolated EELP domains.
We demonstrate that EELP displays a chemokine activity for
human cells at concentrations comparable to those required for
HsEMAPII. The cellular tropism of EELP is different from that of
HsEMAPII, because EELP readily attracts human endothelial
cells but not monocytes. This difference can be reversed by the
mutation of two single residues in the signaling motif of these
chemokines. We propose that EELP is a functional mimic of
HsEMAPII evolved to modulate the cellular environment
encountered by the parasite during infection with the purpose of
escaping the immune response of the host.
Methods
Reagents and plasmids
Entamoeba histolytica genomic DNA was a kind gift of Dr. Mario
A. Rodriguez (Department of Genetics and Molecular Biology,
Cinvestav-IPN). L-[3H] lysine, and HisTrap nickel columns were
from Amersham Biosciences. Restriction enzymes were from New
England Biolabs. Expression vector pET-30 Ek/LIC was from
Novagen. Pfu Ultra DNA polymerase and XL-10 Gold cells were
from Stratagene. pET-20b(+)/C-TyrRS coding for the C-terminal
domain of human tyrosyl-tRNA synthetase was a kind gift from Dr
Schimmel’s lab. Drosophila melanogaster muscle protein 20
(DmMp20) was purchased from Drosophila Genomics Resource
Center and cloned into pET-30 Ek/LIC. Recombinant human
EMAPII (rhEMAPII), tumor necrosis factor-a (TNF-a and
vascular endothelial growth factor (VEGF) were from Peprotech
and lipopolysaccharide (LPS) from Sigma. Affinity purified
antibodies a-EhNtKRS (raised against the peptide sequence 91-
YENKEDFVSLTKMIYRGDIC-110) and a-EELP (raised against
the peptide sequence 741-CLVRTNDVPLIVKDTEL-756 of
EhKRS) were provided by AntibodyBcn. The a-EELP recognizes
EELP domain present in both EhKRS and EhMRS..a-LGL
antibody was a kind gift from Dr. David Mirelman (Department of
Biological Chemistry, Weizmann Institute).
Cell lines
Entamoeba histolytica trophozoites (HM-1:IMSS) were grown
axenically in LYI-S-2 (Trypticase-yeast extract iron serum)
medium supplemented with 100 U of penicillin/ml and 100 mg
of streptomycin sulfate/ml at 37uC [33]. Trophozoites were
harvested during log-phase growth by incubation on ice for
5 minutes, centrifugation at 2506g for 5 minutes and washed in
PBS three times. HUVEC were purchased from Lonza and used
till passage 6 with EGM2 medium (Lonza). Monocytes were
purified from blood of healthy volunteers by Ficoll-paque
centrifugation gradient after leaving to adhere to plastic culture
flasks for 2 hours in RPMI 1640 medium (Invitrogen) supple-
mented with heat-inactivated 10% fetal bovine serum (FBS).
DLD1 cells were maintained in DMEM medium supplemented
with decomplemented 10% FBS. Total human blood was
provided by the Barcelona blood bank (Banc de Sang i Teixits,
www.bancsang.net) after approval of the project by the local ethic
committee (PR(BST)22/2010).
Quantitative RT-PCR
In a six well plate, 1.56106 amoebas were stimulated with
100 ng/ml TNF-a or 100 ng/ml LPS for 6 hours. In other series
of experiments 1.56106 trophozoites were co-cultured with the
same number of DLD1, HUVEC or monocytes, activated or not
with 100 ng/ml LPS for 6 hours. Total RNA was extracted with
Trizol Reagent (Invitrogen Life technologies) following the
protocol described by the manufacturer. cDNA was obtained
from 2 mg of RNA by using the Reverse Transcription System
from Promega. Quantitative RT-PCR were done in a StepOne-
Plus instrument and using Power SYBR Green detection system
from Applied Biosystems. Primers used are detailed in Methods
Author Summary
Amebiasis caused by the parasite Entamoeba histolytica is
one of the leading causes of dysentery worldwide, with an
estimated annual mortality of 100.000. In 10% of patients,
the intestinal infection can spread to internal organs
causing hepatic, lung, and brain abscesses. Little is known
about the strategies used by the parasite to evade or
minimize the inflammatory and immune responses of its
host. In this manuscript we report the discovery that
Entamoeba has evolved a polypeptide that functionally
mimics the activity of a human cytokine (EMAPII) involved
in the regulation of inflammation. This polypeptide termed
EELP (Entamoeba EMAPII-Like Polypeptide) is capable of
attracting human cells, just like its human counterpart but,
unlike EMAPII, EELP does not act on inflammatory cells. We
have characterized the dynamics of gene expression that
regulate EELP synthesis, and we demonstrate that the
protein is produced when Entamoeba encounter inflam-
mation signals produced by their human host. Our
working hypothesis is that EELP is used by the parasite
to shield itself from human inflammation. In general, the
discovery of EELP opens a new avenue of research into the
mechanisms used by Entamoeba to survive their host’s
environment.
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S1. The relative gene expression was determined by calculating
DCt values between EhkrS or EhmrS genes and that of EhtrS (coding
for E. histolytica threonyl-tRNA synthetase). The values were
normalized to non stimulated trophozoites.
Entamoeba lysates, Cellular fractionation and western
blotting
0.256106 amoebas (per well) were stimulated for 24 hours with
100 ng/ml TNF-a, or 100 ng/ml LPS or incubated with 0.56106
monocytes or DLD1 cells previously activated or not with 100 ng/
ml of LPS for 6 hours, in a six-well plate. Cells were washed in
PBS pH 6.8, collected by centrifugation and resuspended in PBS
containing the protease inhibitors 10 mM 2-hydroxymercuri-
benzoate, 100 mM E-64, 5 mM N-ethylmaleimide (NEM), 6 mM
Benzamidine, 0.2 mM Leupeptin, 2 mM phenylmethylsulfonyl
fluoride (PMSF), 1 mM EDTA, 1 mM EGTA and 1% Triton X-
100. The trophozoites were lysed by four freeze-thaw cycles. The
debris and unbroken cells were removed by centrifugation at 2506
g for 5 minutes and supernatant was further spun at 100,0006 g
for 1 hour at 4uC. For cellular fractionation studies the cell pellet
was resuspended at 106/ml in the PBS buffer plus protease
inhibitors but without detergent. Cells were lysed and centrifuged
as described above and the membrane fraction was collected by
ultracentrifugation at 100,0006 g for 1 hour at 4uC. The
membrane pellet was resuspended in PBS buffer plus protease
inhibitors and 1% Triton X-100. For protein processing assays,
protein extracts were prepared in the same way, but without
adding protease inhibitors to the extract. Protein concentrations
were calculated with Bradford reagent (Bio-Rad). 35 mg of total
protein per sample was resuspended in Laemmli buffer, separated
by 12% SDS-PAGE and immunoblotted to polyvinyldifluoride
(Immobilon-P, Millipore) membranes.
Immunoprecipitation and proteomics analysis
A total of 66106 amoebas were lysed using 1% Triton X-100
containing buffer as described above. Crude extracts were clarified
by centrifugation at 10,0006 g for 10 minutes and further
precleared with 35 ml of protein G-Sepharose beads for 1 hour
at 4uC. Two additional preclearings were performed. For
immunoprecipitations, precleared lysates were incubated over-
night at 4uC with 2 mg of the affinity purifed a-EELP antibody, or
with 10 ml of pre-immune serum. Subsequently, 30 ml of protein
G-Sepharose beads were added to the lysates for 3 additional
hours. Proteins in the immunoprecipitates were separated by SDS-
PAGE and coomassie blue stained. Coomassie stained bands were
cut and analyzed by the Proteomics facility of the Barcelona
Science Park and the Mass Spectrometry core facility of the
Institute for Research in Biomedicine. Samples were trypsinised,
and the resulting peptides were sequenced by nano-LC-MS/MS
obtaining different fragmentation spectra. A database search was
performed with Proteome Discoverer software v1.2.0.208
(Thermo) using Sequest and Mascot engines and SWISSPROT
and NCBI nr databases. Peptide mass tolerance was 10 ppm and
the MS/MS tolerance was 0.8 Da. Only proteins containing
peptides with confidence higher than 95% were considered.
Confocal microscopy
Trophozoites on prewarmed cover slips were fixed with 4% (w/
v) paraformaldehyde for 1 hour at 37uC, incubated with 0.1 M
glycine in PBS for 15 minutes at room temperature, permeabilized
with 0.2% (v/v) Triton X-100 for 15 minutes and blocked with
1% (w/v) BSA in PBS at 37uC for 30 minutes. Samples were
incubated with chicken a-NtEhKRS (1:1000) and rabbit a-EELP
(1:500) antibodies for 1 hour. Subsequently, cells were washed
with PBS and incubated with alexa fluor 555-labeled goat a-rabbit
and alexa fluor 488-labeleld goat a-chicken secondary antibodies
(Molecular Probe; 1:1000) in blocking solution at room temper-
ature for 1 hour. Finally, cells were washed and counterstained
with DAPI 1 mg/ml (Sigma), and pictures were taken with a
Spectral Confocal Microscope Leica SP5. Fluorescence intensity
was quantified with ImageJ free software.
DNA amplification and cloning
Genomic DNA from different Entamoeba species was obtained
using Puregene Tissue Core Kit B (Qiagen). Amplification of krS
and mrS genes from Entamoeba nuttallii (accession number
HQ121505, HQ121508), Entamoeba moshkovskii (HQ121506,
HQ121507) and Entamoeba terrapinae (HQ121509) was performed
using primers (see Methods S1) designed from the alignment of
known Entamoeba krS and mrS genes. The 2307 base pair gene
coding for E. histolytica KRS (GenBank XM645508) was amplified
by PCR from E. histolytica genomic DNA using Pfu Ultra DNA
polymerase (see Methods S1 for primer sequences). The amplified
DNA fragment was cloned into the pET-30 Ek/LIC vector to
yield plasmid pET-30-EhKRS. The Ct region of the gene and the
gene without the EMAPII-like domain were also amplified and
cloned into the pET-30 Ek/LIC vector to yield pET-30-EhCtKRS
(also named pET-30-EELP) and pET-30-EhKRSDCt plasmids,
respectively. The correct sequence and orientation of the genes
were checked by sequencing the constructions entirely. Mutated
constructs were performed with QuickChange Site-directed
mutagenesis kit (Stratagene) following the manufacturer’s protocol.
Enzyme overexpression and purification
Escherichia coli BL21 (DE3) cells transformed with the pET-30
constructs were grown at 37uC to an optical density A600 nm= 0.6.
Protein expression was induced with 1 mM IPTG for 4 hours at
37uC. Initial purification on nickel affinity columns was performed
using standard procedures at 4uC. Binding and wash buffer had a
room temperature pH of 7.8 and contained 50 mM Tris/HCl,
100 mM NaCl buffer, and 20 mM imidazole. Elution buffer was
the same but it contained 500 mM imidazole. Subsequent
visualization on coomassie blue stained 12% polyacrylamide gel
showed the protein preparations were over 99% pure. The protein
solutions were dialyzed in pyrogen-free buffer (50 mM TrisHCl,
100 mM NaCl, 50% Glycerol), passed through polymyxin resin
(Pierce) and treated with Triton X-114 (Calbiochem) at final
concentration of 1% [34] to eliminate endotoxins. Finally, proteins
were passed through a 0.22 mm PES filter. Protein concentrations
were determined by Bradford assay [35]. For the aminoacylation
assays, final concentrations of the EhKRS and EhKRSDCt
proteins were determined by active site titration as described in
the literature [36].
Protein processing assays
Purified EhKRS was digested with different concentrations of
E.histolytica extracts or human leukocyte elastase (Sigma) for 5, 15
or 30 minutes at 37uC in the presence or absence of protease
inhibitors. After treatment samples were mixed with Laemmli
buffer and heated at 90uC for 5 minutes to stop the reaction.
Samples were loaded onto a 12% SDS-PAGE gel and analyzed by
immunobloting. Edman degradation analysis of these samples was
performed at the Proteomics and Bioinformatics facility of
Universitat Auto`noma de Barcelona, a member of ProteoRed
network, to identify the point or points of proteolytic cleavage of
the purified protein.
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Figure 1. Bioinformatic analysis of EELP. (A) Protein alignment of EELP sequences from different Entamoeba species. (B) Protein alignment of
mature EMAPII from Homo sapiens (HsEMAPII), C-terminal EMAPII-like domain of human tyrosyl-tRNA synthetase (HsCtYRS) and C-terminal domain of
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tRNA substrate preparation
Constructions containing a T7 promoter fused with the tRNA
genes of interest were obtained and in vitro transcribed using T7
RNA polymerase and according to standard protocols [37].
Transcripts were separated on denaturing PAGE, full-length
tRNAs were eluted from the gel using an electroelution apparatus
(Schleicher & Schu¨ll) and refolded (80uC followed by gradual
cooling in the presence of 1 mM MgCl2). Finally, aminoacylation
plateaus were used to calculate the concentration of active
molecules for each tRNA preparation.
Aminoacylation assays
Aminoacylation of tRNA was performed at 37uC in 100 mM
Hepes, pH 7.2, 6 mM lysine, 30 mM MgCl2, 30 mM KCl,
0.5 mM DTT, 5 mM ATP, 0.1 mg/ml BSA, 500 Ci/mol L-
[3H] lysine and varying concentrations of tRNA transcripts (0.5–
20 mM). Reactions were initiated by addition of pure enzyme and
samples of 22 ml were spotted onto Whatman 3MM discs at
varying time intervals. Radioactivity was measured by liquid
scintillation. Enzyme concentrations were experimentally deter-
mined in order to obtain linear velocities for kinetic constant
determination. Kinetic constants were obtained from Lineweaver-
Burk plots using a minimum of two independent measurements
and five tRNA concentrations.
Computational analyses
Initial database searches were performed with BLAST [38] in
the NCBI public databases (http://www.ncbi.nlm.nih.gov/).
Additional searches were performed at the Entamoeba genome
project [39] websites (www.tigr.org and www.sanger.ac.uk).
Protein sequence alignments were performed with CLUSTALW
[40]. Phylogenetic trees of EELP amino acids sequences were
calculated using the packages PHYLIP [41], PHYML [42,43] and
MrBAYES [44]. Maximum parsimony and distance trees were
calculated with the programs PROTPARS and PROTDIST, and
their numerical robustness was measured by bootstrap with the
program CONSENSE. Maximum likelihood trees were calculated
with the program PHYML and evaluated by bootstrap analysis.
Bayesian phylogeny was inferred with MrBAYES.
Cell migration assays
Cells were resuspended in chemotaxis media (RPMI 1640
containing 0.5% FBS for monocytes and EBM-2 basal medium for
HUVEC) at a concentration of 16106 cells/ml. Recombinant
human EMAPII (rhEMAPII), HsCtYRS, EhKRS, EhKRSDCt,
and EELP were diluted in chemotaxis medium and placed in the
lower well of a 24-well transwell Boyden chemotaxis plate (Costar).
The concentration of the stimuli was tipically 1 nM. In some
experiments of monocyte migration, supernatants from HUVEC
cells cultured with 1 nM EhKRS, EhKRSDCt, EELP or EhMRS
proteins were placed in the lower well of a chemotaxis plate.
200 ml of cells (0.26106 cells/ml) were plated in the upper well.
The polycarbonate membranes separating cells from lower wells
had 5 mm pore diameter for monocytes and 8 mm for HUVEC.
The filled chemotaxis transwell plates were incubated at 37uC in a
humidified CO2 incubator for 3 hours for monocytes and
16 hours for HUVEC cells. After incubation, non migratory cells
on the upper surface of the filter were removed by wiping with a
cotton swab, and migratory cells were fixed and stained with
hemacolor (Merck). The number of migrated cells was counted by
taking photographs under inverted light microscope using a 206
objective and migration was plotted either as mean of number of
cells in each high power field (HPF) or as migration index
(MI= number of migrating cells in each condition/number of
migrating cells in basal medium). Data are presented as Mean 6
SEM from at least three independent experiments. The data
significance was analyzed by mean of t tests.
Calcium flux assays
HUVEC and monocytes were stained with Fluo-4 by using the
Fluo-4 NW calcium assay kit from Molecular Probes and following
the manufacturer’s protocol. Cells were stimulated during data
acquisition with 10 nM rhEMAPII, HsCtYRS, EhKRS,
EhKRSDCt, EELP or HumEELP. For monocytes, intracellular
calcium flux was recorded in a XL cytometer (Coulter) for
240 seconds and expressed as relative fluorescence units (RFU)
versus time acquisition. Data were analyzed with FlowJo software
(Tree Star, Ashland, OR). For HUVEC, calcium influx was
monitored in a Spinning Disk microscope (Perkin Elmer) and data
analyzed with Volocity software (Perkin Elmer).
Cell Binding Assay
Monocytes and HUVEC cells (0.36106/well) were seeded onto
six-well dishes. 100 nM EELP, HumEELP, HsCtYRS or
DmMp20 (Drosophila melanogaster muscle protein of 25 kDa; see
Figure S1A and C) were added to the culture medium for
60 minutes at 37uC. After that, the cells were harvested, washed
three times with cold PBS, and lysed in lysis buffer (25 mM Tris/
HCl, pH 7.4; 150 mM NaCl; 5 mM EDTA; 1 mM DTT; 0.5%
Triton X-100; Complete proteases inhibitors (Roche Molecular
Biochemicals)). The extracted proteins (35 mg) were resolved by
SDS-PAGE, transferred to Immobilon membranes and blotted
with anti-His antibody (Amersham Biosciences).
Results
Genomic analysis of Entamoeba species
The analysis of available genomic data for the Entamoeba species
E. histolytica, E. dispar and E. invadens, and of new sequences
obtained by us through the sequencing of E. nuttalli, E. moshkovskii
and E. terrapinae genomic DNA (Figure 1A and Figure S1B)
clearly shows that Entamoeba species contain a DNA sequence
coding for a HsEMAPII-like domain in the KRS and MRS genes
(Figure 1B). In all the Entamoeba species analyzed these domains
are located at the C-terminal of KRS and MRS. In the case of E.
histolytica the two domains are 99% identical to each other.
The C-terminal domain of Entamoeba MRS (EhCtMRS) can be
found in many other species, including Dictyostelium discoideum, a
slime mould considered one of the closest known relatives of
Entamoeba lysyl-tRNA synthetase (EhCtKRS). The boxed sequence corresponds to the heptapeptide migration motif. (C) Phylogenetic analyses of
EELP protein sequences from different Entamoeba species. Numbers on each branch correspond to bootstrap values in the distance consensus tree.
doi:10.1371/journal.pntd.0001398.g001
Table 1. EhCtKRS is dispensable for KRS activity.
Vmax (s21) Km (mM) Vmax/Km tRNALys
EhKRS 0.1860.09 5.2360.007 0.034 E. histolytica
EhKRSDCt 0.02560.006 30.9665.7 0.00081 E. histolytica
Kinetic parameters for EhKRS and EhKRSDCt proteins.
doi:10.1371/journal.pntd.0001398.t001
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Entamoeba. However, Entamoeba KRSs represent the only known
example of a KRS containing this type of domain in their
structure. The high sequence identity shared by the two domains,
and the fact that the KRS domain is unique to Entamoeba, support
the idea that EhCtKRS resulted from a duplication of EhCtMRS
that integrated into the Entamoeba KRS gene after Entamoeba
separated from the slime molds.
We computationally tested whether EhCtKRS and EhCtMRS
are under the same evolutionary constraints, or whether they are
functionally separated. All the phylogenetic trees calculated clearly
show that the evolution of the domains is intra-specific and not
linked to enzyme type (Figure 1C).
EhCtKRS is dispensable for EhKRS aminoacylation activity
The kinetic analyses of EhKRS and the truncated variant
EhKRSDCt confirmed the limited role of the EELP in the
aminoacylation reaction catalyzed by EhKRS (Table 1). Ablation
of EELP from EhKRS (EhKRSDCt) has a moderate effect on
aminoacylation, reducing the Vmax/Km ratio approximately
forty-fold. Although this reduction is significant, EhKRSDCt
maintains a level of activity well above that commonly
documented to be required for cellular viability [45,46,47]. This
fact, together with the results from our computational analyses and
the almost identical sequence of the EELP domains from EhMRS
and EhKRS, indicate that these two domains are likely performing
additional functions beyond protein synthesis.
EhKRS and EhMRS, but not other aaRSs, are upregulated
by inflammation signals
It has been shown that the expression of human aaRS involved
in cell-signaling functions responds to cytokine signals [48]. For
example, human AIMP1, an aaRS-associated protein, is up-
regulated by tumor necrosis factor-a (TNF-a) [49]. To test
whether EhKRS or EhMRS were responsive to human inflam-
matory signals we analyzed the transcription levels of the genes
coding for both proteins by quantitative RT-PCR in parasites
treated with human TNF-a. EhKRS and EhMRS mRNAs, but
not threonyl-tRNA synthetase (EhTRS) mRNA, were up-regulat-
ed roughly 3 times in cells treated with TNF-a (Figure 2A).
Thus, EhKRS and EhMRS seem to be regulated differently
from other aaRS, and their expression is increased when the
parasite is exposed to inflammatory cytokines. We also quantified
EhKRS and EhMRS gene expression in co-cultures of amoebae
with DLD1 colonic epithelial cells, endothelial (HUVEC) cells, or
human primary monocytes. EhKRS and EhMRS were signifi-
cantly and specifically up-regulated in contact with lipopolysac-
charide (LPS)-activated monocytes. EhKRS up-regulation was
confirmed by immunofluorescence (Figure 2B) and western blot
(Figure S2) analyses. All together these data demonstrate that
EhMRS and EhKRS are specifically up-regulated when amoebae
are exposed to host-induced inflammatory signals.
Molecular identification and cellular localization of EELP
Confirmation of the existence of EELP as standalone domain
after cleavage from EhKRS or EhMRS was experimentally
determined. Crude extracts of amoebas were immunoprecipitated
with the anti-EELP antibody, the immunoprecipitated material
was resolved by SDS-PAGE electrophoresis (Figure S3A), and
proteins bands with molecular weight approximating the expected
size of EELP were sequenced by mass spectrometry (Figure S3B
and C). Indeed, a protein band approximating the molecular
weight of recombinant EELP was identified whose sequence
unambiguously corresponds to EELP, proving that EELP is
produced by Entamoeba as a processed product of full length MRS
and/or KRS.
We then investigated the cellular localization of EELP with
antibodies against the N- and C-terminal sequences of EhKRS
(a-EhNtKRS and a-EELP, respectively). Due to their high
sequence similarity in the EELP region, both EhMRS and
EhKRS are recognized by a-EELP. On the other hand, a-
EhNtKRS specifically recognizes EhKRS. The a-EhNtKRS
antibody clearly stained the Entamoeba surface, while the a-EELP
antibody stained both the plasma membrane and the cytosol
(Figure 2C). Immunoblot analyses of E. histolytica cellular
fractions revealed a band of ,90 kDa and another of 27 kDa
reactive with the a-EELP antibody, and a band of ,68 kDa
reactive with the a-NtEhKRS, all of them present in the
membrane fraction of the parasite’s extracts (Figure 2D). Thus,
three forms of EhKRS are found in membrane associated
material: full-length EhKRS, a C-terminally cleaved EhKRS,
and the cleaved C-terminal domain. This opens the possibility that
the C-terminal domain of EhKRS is cleaved and released from the
full-length enzyme at the surface of the parasite.
Protease processing releases the EELP domain
To study the possible processing of EhKRS we treated purified
recombinant enzyme with a protein extract from Entamoeba (which
contains parasite proteases) (Figure 3A), and with mammalian
elastase (Figure 3B). We observed that EhKRS is cleaved readily,
releasing a protein band of 22 kDa recognized by anti-EELP
antibodies. Edman degradation analysis of elastase digestion
products showed that first amino acids present in our sample
were KEVLD (Figure 3B), confirming the cleavage of EhKRS
and the production of EELP. We also observed that this process
also applies to EhMRS (Figure 3C). Processing is blocked by
cysteine protease inhibitors. Thus, EELP can be proteolitically
cleaved from EhKRS and EhMRS by either parasite or host
proteases.
Figure 2. EhKRS and EhMRS are up-regulated by inflammation signals. (A) qRT-PCR of EhKRS (closed bars) and EhMRS (open bars) gene
expression relative to Entamoeba histolytica threonyl-tRNA synthetase (EhTRS). Trophozoites stimulated with 100 ng/ml LPS or 100 ng/ml TNF-a or co-
cultured with endothelial cells (HUVEC), colonic epithelial cells (DLD1), or primary monocytes (Monos) pre-activated (Act) or not with 100 ng/ml LPS
for 6 h. Values are relative to non-stimulated amoebae (ctl) and depicted as mean 6 SD from at least two independent experiments performed in
triplicate. (B) Quantification of EhKRS protein expression in trophozoites stimulated for 6 hours (open bars) and 24 hours (closed bars) with 100 ng/ml
LPS or 100 ng/ml TNF-a or co-cultured with monocytes (Monos) or monocytes previously activated with LPS for 6 hours (Act Monos). The
fluorescence units were normalized to non-stimulated (ctl) trophozoites and depicted as mean6 SD from three different experiments. The number of
cells counted per each condition was n = 40. (*** p,0.0001 vs ctl). Inserts show microphotographs of immunodetection of EhKRS protein (a-NtEhKRS)
in trophozoites at 24 hours of stimulation. (C) Immunolocalization of EhKRS in Entamoeba trophozoites using affinity purified antibodies against
EhKRS N-terminal (a-NtEhKRS) and C-terminal (a-EELP) domains. Controls of secondary antibodies merged with DAPI are shown in bottom row. (D)
EhKRS cellular localization was evaluated by immunoblot analysis of E. histolytica lysates, marked as T (whole cell lysate), C (cytoplasmic fraction), and
MB (membrane bound fraction). Specific antibodies of cytoplasmic fraction (a-actin) and membrane fraction (a-LGL) were used. a-EELP antibody
recognizes a full length protein (top panel) and a C-terminal cleaved product (bottom panel). a-NtEhKRS (1:250), a-EELP (1:50), a-LGL (1:1000) and a-
actin (1:1000) antibody dilutions were used.
doi:10.1371/journal.pntd.0001398.g002
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Figure 3. EhKRS protease processing. Immunoblots analysis with a-EELP antibody of recombinant EhKRS protein digestions using Entamoeba
lysates (A) or human leukocyte elastase (B). (A) 1 mg recombinant EhKRS was incubated at 37uC for 30 minutes without E. histolytica crude extract (Eh
CE; lane 1) or with 0.5 mg Eh CE (lane 2–4); 1 mg Eh CE (lane 5–7); 5 mg Eh CE (lane 8–10) or 5 mg Eh CE plus protease inhibitors (lane 11–13) for 5, 15 or
30 minutes. (B) Digestion of 1 mg recombinant EhKRS protein with elastase for 30 minutes at 37uC. (C) EhMRS protease processing. Digestion of 1 mg
recombinant EhMRS at 5, 15 and 30 minutes with 1 mg of Eh CE (lane 2–4) or 5 mg Eh CE (lane 5–7). Recombinant EhMRS control without Eh CE (lane
1). Digestion products were detected by immunoblot using a-EELP antibody. Arrow shows EELP product resulting from recombinant EhKRS or
EhMRS. Asterisk denotes recombinant EELP with 6 His tag plus 36 amino acids at the N-terminal. Boxed sequence corresponds to the N-terminal
sequence of EELP after digestion from EhKRS by elastase, as determined by Edman degradation.
doi:10.1371/journal.pntd.0001398.g003
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EELP mimics the chemotactic effect of human EMAPII
Human EMAPII and the EMAPII-like domain of YRS
(HsCtYRS) display potent leukocyte and monocyte chemotaxis
activity after proteolytic processing [22]. We evaluated whether
EELP chemoattracted endothelial primary cells and monocytes in
a Boyden chamber migration assay. EELP promoted migration of
human vascular endothelial cells (HUVEC) as efficiently as
HsEMAPII or HsCtYRS (Figure 4A). This effect was dependent
Figure 4. Effect of EELP on host cell migration. (A) Endothelial cell and (B) monocyte chemotaxis towards different EMAPII bearing proteins.
VEGF (1 nM) was used as a common chemoattractant for both cells. Data are the mean6 SEM for at least three different experiments. Inserts show a
representative photograph of cell migration. Pore membranes for HUVEC and monocyte migration were of 8 mm diameter and 5 mm diameter,
respectively. Cells are stained in purple. Migration is plotted as Migration Index (MI; number of cells migrating in each condition/number of cells
migrating in basal medium). Ctl, basal medium in the lower well; VEGF, vascular endothelial grothw factor; rhEMAPII, recombinant human EMAPII;
HsCtYRS, C-terminal EMAPII-like domain of human tyrosyl-tRNA synthetase; EELP, Entamoeba EMAPII-like polypeptide; EhKRS, lysyl-tRNA synthetase
of Entamoeba; EhKRSDCt, EhKRS depleted of EELP domain; HumEELP, humanized EhCtKRS (see Figure S1 and text). *** p,0.0001 vs ctl.
doi:10.1371/journal.pntd.0001398.g004
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on EELP concentration (Figure S4). The full length EhKRS, or
its truncated form (EhKRSDCt) did not show this effect
(Figure 4A).
We analyzed whether EELP acted in synergy with VEGF to
induce HUVEC chemotaxis, but no additive activity could be seen
(Figure S5). In contrast to HsEMAPII, EELP did not induce
migration of monocytes (Figure 4B and Figure S6). Since
HsEMAPII was reported to induce calcium mobilization in
monocytes, we checked whether a calcium signalling was also
triggered by EELP. While HsEMAPII induced calcium mobilisa-
tion in HUVEC cells (Movie S1) and monocytes (Figure 5A),
EELP only mobilized calcium in endothelial cells (Movie S2 and
Figure 5A).
Because EELP triggers signalling in endothelial cells but not
in monocytes we examined whether the chemokine binds
differently to these two cell types. HUVEC and primary
monocytes were incubated with purified EELP and HsCtYRS
for 60 minutes, and binding was assessed by western blotting.
EELP was internalized both in HUVEC and monocytes
(Figure 5B), indicating that the different activity of EELP
towards these two cell types may depend upon interactions with
intracellular partners.
To understand the reason behind the functional differences
between human EMAPII and EELP we compared the sequences
of the two proteins. It is known that the cytokine activities of
HsEMAPII and HsCtYRS depend upon a heptapeptide sequence
called ‘migration motif’ [50,51]. The only differences between this
motif in human HsCtYRS and EELP are at two positions
(Figure 1B and Figure S1D). Mutation of these positions in
EELP to the HsCtYRS sequence turned the Entamoeba domain
into a monocyte chemokine (Figure 4B and Figure S7) that
induces calcium mobilization in these cells (Figure 5A). Thus, the
functional differences between EELP and HsEMAPII or
HsCtYRS are caused by changes in their ‘migration motifs’.
Figure 5. Calcium mobilisation and cellular internalization of EELP. (A) Calcium flux was observed by Fluo-4 fluorescence in monocytes
stimulated with 10 nM rhEMAPII, HsCtYRS, EhKRS, EhKRSDCt, EELP, and HumEELP. An increase in fluorescence proves increase in cytoplasmic calcium
and was monitored as indicated in Methods. RFU, relative fluorescence units; the rest of abbreviations are the same as listed in Figure 4. Arrow
indicates when stimuli were added. (B) EELP and HumEELP are internalized in endothelial cells and monocytes. These cells were incubated for 1 hour
with 100 nM of His tagged purified proteins. Cell extracts were analyzed by western blot with a-His antibody. Control of protein loading was
evaluated with a-tubulin antibody. DmMp20; recombinant Drosophila melanogaster Muscle protein of 25 kDa (see also Figure S1A).
doi:10.1371/journal.pntd.0001398.g005
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Monocytes are chemoattracted by supernatants of
EELP-stimulated HUVEC
We asked whether the chemoattraction of endothelial cells by
EELP may represent a strategy to shield the parasite from contact
with immune cells. To test this hypothesis we analyzed whether
HUVEC treated with EELP generated a chemotactic response
from monocytes. We incubated HUVEC with EELP for 1, 4, and
14 hours, and used the supernatants to try to induce monocyte
migration. We observed that the supernatants from HUVEC cells
treated with EELP for 14 hours were able to induce monocyte
migration (Figure 6A). No chemotactic activity could be observed
when we used the supernatants from HUVEC treated with
EhKRS or EhKRSDCt for 14 hours (Figure 6B). Thus, EELP
indirectly induces monocytic migration through the action on
endothelial cells.
Discussion
New signaling domains can evolve within proteins that provide
suitable structural and functional platforms for the selection of new
functions. Multi domain aaRS are a clear example of a house-
keeping protein family that can readily incorporate new functions
through the evolution of additional domains [52]. In many cases
these domains evolve from RNA-binding structures that comple-
ment the original functional core of these proteins. The emergence
of cell-signaling domains within larger house-keeping enzymes
may be favored by the intrinsic structural and functional stability
of the later, which facilitate the development of activation
mechanisms based on the action of proteases.
Multicellular organisms have evolved new signaling systems to
avoid, modulate, or respond to the immune challenges built by
their hosts. The nature of such strategies in the infectious cycle of
Entamoeba has not been well explored, but the fact that the parasite
is capable of traversing several tissue barriers and infect different
organs argues in favor of the existence of mechanisms designed to
modulate the host immune response [5]. In this context, the
expression of a mimic of a human cytokine could contribute to the
modulation of host signaling pathways to the parasite’s advantage.
We have discovered that two aaRS from the parasite E.
histolytica contain a C-terminal domain that structurally mimics the
human cytokine EMAPII. This discovery underlines again the
facility with which aaRS can evolve to incorporate signaling
activities. Until now, however, aaRS-associated signaling functions
had not been found to cross species barriers. Our study
demonstrates that, upon exposure to inflammatory signals,
Entamoeba histolytica overexpresses EhKRS and EhMRS. Parasite
proteases and human elastase are capable of processing EhKRS
and EhMRS to liberate their respective C-terminal domains,
which are 99% identical in sequence and we have named as
EELP. Mass spectrometry analysis demonstrates that EELP can be
found in Entamoeba extracts, and immunolocalization studies show
that EELP localizes to the peripheral area of the parasite’s cytosol,
in close proximity to the cell membrane.
Reported HsEMAPII effects include chemotactic attraction of
monocytes, dendritic cells and endothelial cells, induction of
apoptosis in lymphocytes, and TNF-a production by monocytes/
macrophages [30,53,54]. In contrast, EELP attracts human
endothelial cells but not human monocytes, and this cellular
specificity depends on the sequence of the signaling peptide of this
protein. In turn, endothelial cells activated by EELP generate a
chemoattractant signal for monocytes.
Amebic chemoattractant activity present in non-vesicular
membranes of the parasite has already been described [55,56],
and is possibly linked to the molecular interaction between the
invading parasite and the immune response. In the initial
interactions of Entamoeba with host cells in the epithelial mucosa,
a local inflammatory response is mounted by the host. Activated
monocytes/macrophages produce TNF-a, which induces parasite
motility that is essential for pathogenic amebiasis [57]. Our data
show that TNF-a up-regulates EhKRS and EhMRS gene
expression, which are processed to EELP by proteases to induce
chemotaxis of endothelial cells.
Figure 6. The effect of conditioned HUVEC medium on monocyte migration. (A) Number of monocytes that have migrated to 1 nM
rhEMAPII or supernatants from HUVEC cultured with EELP for 1, 4 or 14 hours in the lower wells of a 24-transwell Boyden plate or (B) that have
migrated to 1 nM rhEMAPII, 1 nM EELP, supernatants from HUVEC cultured for 14 hours with 1 nM EhKRS (SN EhKRS), 1 nM EhKRSDCt (SN EhKRSDCt)
1 nM EELP (SN EELP) or 1 nM EhMRS (SN EhMRS). Values are plotted as Mean 6 SEM of three independent experiments.
doi:10.1371/journal.pntd.0001398.g006
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Activated endothelial cells produce interleukin-6 (IL-6), which,
through signaling to its intracellular target STAT3, plays a central
role in intestinal epithelial cell homeostasis [58,59]. EELP could,
therefore, influence the immune response through its chemotactic
activity. Our current hypothesis for the biological function of
EELP posits that the presence of endothelial cells attracted by the
chemokine during Entamoeba infections directs the immune system
towards a repairing response, maintaining mucosal homeostasis,
preventing inflammation, and improving parasite survival and
fitness.
The affinity of HsEMAPII for monocytes can be completely
abolished through two residue changes in EELP without affecting
the activity of either protein over endothelial cells. This fact indicates
that the mechanism of action of EMAPII and EELP is complex, and
coupled to cell-type specific pathways that respond differently to the
sequence and/or structure of this family of cytokines.
Supporting Information
Figure S1 Experimental and computational compari-
sions of EELP and EMAPII. (A) coomassie blue staining of
purified 6His-tagged HsCtYRS, EhMRS, ,EhKRS, EELP,
EhKRSDCt, and HumEELP. DmMp20 is an unrelated protein
used as reference. (B) protein sequence alignement of EhCtKRS,
EhCtMRS, and human EMAPII. Both EhCtKRS and EhCtMRS
are 99% identical (only Ala133 in EhCtKRS is changed to Ser in
EhCtMRS) and are collectively called EELP. (C) Diagram
showing the relative length of the proteins, and the position of
the EMAPII domain (blue box). The red box marks the position of
the heptapeptide migration motif. (D) Alignment of the heptapep-
tide migration motif of human EMAPII and HsCtYRS, and EELP
from several Entamoeba species. The two residues mutated to obtain
the humanized domain of EELP (HumEELP) are boxed in grey.
Only the peptide migration motif is shown. For full comparison of
the human and Entamoeba sequences see Figure 1B.
(TIF)
Figure S2 EhKRS is upregulated by inflammation
signals. Expression of EhKRS detected by immunoblot with a-
NtEhKRS antibodies. Entamoeba trophozoites were stimulated for
24 h with 100 ng/ml TNF-a, 100 ng/ml LPS, or co-cultured with
primary monocytes (monos) or DLD1 cells pre-activated or not
with 100 ng/ml LPS for 6 h. Gal/GalNAc lectin identified with
the a-LGL antibody was used as a control.
(TIF)
Figure S3 Identification of EELP in immunoprecipitat-
ed Entamoeba extracts by mass spectrometry. (A)
Coomassie blue stained SDS-PAGE of amoeba crude extracts
immunoprecipitated with a-EELP. Arrows mark the bands
corresponding to endogenous (left) and recombinant(right, 6His-
tagged) EELP. (B) Peptide sequence and fragmentation spectra
obtained after trypsin digestion and Nano-LC-MS/MS analysis of
the band shown in Figure S3A. (C) The peptide sequences
determined by mass spectrometry analysis are underlined in the
EELP sequence (Coverage = 17,5 and score = 238,9.).
(TIF)
Figure S4 Dose-dependent HUVEC migration induced
by EELP. The number of HUVEC cells that migrated in
response to increasing concentrations of EELP in a Boyden
chemotaxis plate assay.
(TIF)
Figure S5 No synergistic effect of EELP and VEGF over
HUVECmigration. The number of HUVEC cells that migrated
in response to increasing concentrations of VEGF in the presence
(1 nM), or absence of EELP, in a Boyden chemotaxis plate assay.
(TIF)
Figure S6 Lack of EELP chemotaxis activity towards
monocytes. The number of primary human monocytes that
migrated in response to 1 nM rhEMAPII, 1 nM HsCtYRS, or
increasing concentrations of EELP, in a Boyden chemotaxis plate
assay.
(TIF)
Figure S7 Humanized EELP recovers chemotaxis activ-
ity towards monocytes. The number of human primary
monocytes that migrated in response to EELP, humanized EELP
(humEELP), rhEMAPII and HsCtYRS. The top panels show
representative microphotographs for each condition. The bottom
panel shows a histogram from 3 independent experiments. Data
are plotted as mean 6 SEM.
(TIF)
Movie S1 Calcium influx by rhEMAPII. Fluo-4 stained
HUVEC cells recorded with a confocal microscope spinning disk
and stimulated with 10 nM rhEMAPII. Time is accelerated 10
fold. Scale bar, 7 mm.
(AVI)
Movie S2 Calcium influx by EELP. Fluo-4 stained HUVEC
cells recorded with a confocal microscope spinning disk and
stimulated with 10 nM EELP. Time is accelerated 10 fold. Scale
bar, 7 mm.
(AVI)
Methods S1 Sequence of primers used in this study.
(DOC)
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